- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia ; volume:32 ; number:8 ; day:20 ; month:7 ; year:2018 ; pages:1768-1777 ; date:8.2018
Leukemia ; 32, Heft 8 (20.7.2018), 1768-1777, 8.2018
- Urheber
- Beteiligte Personen und Organisationen
-
Dearden, Claire
Zinzani, Pier Luigi
Delgado, Julio
Karlin, Lionel
Robak, Tadeusz
Gladstone, Douglas E.
le Coutre, Philipp
Dietrich, Sascha
Gotic, Mirjana
Larratt, Loree
Offner, Fritz
Schiller, Gary
Swords, Ronan
Bacon, Larry
Bocchia, Monica
Bouabdallah, Krimo
Breems, Dimitri A.
Cortelezzi, Agostino
Dinner, Shira
Doubek, Michael
Gjertsen, Bjorn Tore
Gobbi, Marco
Hellmann, Andrzej
Lepretre, Stephane
Maloisel, Frederic
Ravandi, Farhad
Rousselot, Philippe
Rummel, Mathias
Siddiqi, Tanya
Tadmor, Tamar
Troussard, Xavier
Yi, Cecilia Arana
Saglio, Giuseppe
Roboz, Gail J.
Balic, Kemal
Standifer, Nathan
He, Peng
Marshall, Shannon
Wilson, Wyndham
Pastan, Ira
Yao, Nai-Shun
Giles, Francis
SpringerLink (Online service)
- DOI
-
10.1038/s41375-018-0210-1
- URN
-
urn:nbn:de:101:1-2018083113123133227444
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kreitman, Robert
- Dearden, Claire
- Zinzani, Pier Luigi
- Delgado, Julio
- Karlin, Lionel
- Robak, Tadeusz
- Gladstone, Douglas E.
- le Coutre, Philipp
- Dietrich, Sascha
- Gotic, Mirjana
- Larratt, Loree
- Offner, Fritz
- Schiller, Gary
- Swords, Ronan
- Bacon, Larry
- Bocchia, Monica
- Bouabdallah, Krimo
- Breems, Dimitri A.
- Cortelezzi, Agostino
- Dinner, Shira
- Doubek, Michael
- Gjertsen, Bjorn Tore
- Gobbi, Marco
- Hellmann, Andrzej
- Lepretre, Stephane
- Maloisel, Frederic
- Ravandi, Farhad
- Rousselot, Philippe
- Rummel, Mathias
- Siddiqi, Tanya
- Tadmor, Tamar
- Troussard, Xavier
- Yi, Cecilia Arana
- Saglio, Giuseppe
- Roboz, Gail J.
- Balic, Kemal
- Standifer, Nathan
- He, Peng
- Marshall, Shannon
- Wilson, Wyndham
- Pastan, Ira
- Yao, Nai-Shun
- Giles, Francis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia
Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia
Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)